Search
FibroGen Ord Shs
KYNBAdd to Watchlist
3.680USD
+0.110+3.08%
Close 11-11 16:00（ET）
14.90MMarket Cap
0.09P/E TTM
Today
+3.08%
5 Days
-7.07%
1 Month
-39.77%
6 Months
-45.88%
Year to Date
-58.09%
1 Year
-62.98%
Key Figures
3.610Open
3.820High
100.00Volume
0.09P/E TTM
LossP/E Dynamic
--Dividend TTM
0.00%Turnover Ratio
3.570Prev. Close
3.600Low
370.00Turnover
LossP/E Static
-0.50P/B
0.00%Div Yield TTM
-41.17%ROA
10.47052wk High
0.02Volume Ratio
-47.58MNet Profit
4.05MShares
40.4711EPS TTM
1.03Beta
--ROE
3.50052wk Low
16.81%Amplitude
-81.45%Gross Margin
14.90MMarket Cap
0.05Reward/Risk
3.50%Risk Rate
Analyst Rating
FibroGen Ord Shs Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
FibroGen Ord Shs Latest Earnings Call Transcripts
KYNB Q2 2026 Earnings Call: $95.7M Liquidity and Q4 Clinical Catalysts
KYNB’s Q2 2026 earnings call covered $95.7 million in liquidity, a runway into 2028 and Q4 catalysts for FG-3246 and roxadustat.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
2.96/-3.18
Revenue / Forecast
-1.47M/2.01M
FibroGen Ord Shs Profile
SectorPharmaceuticals
Ticker SymbolKYNB
Number of employees0
Country
Ownership
| Shareholders | Proportion |
|---|---|
| Armistice Capital LLC | 9.88% |
| Vanguard Capital Management, LLC | 3.87% |
| Acadian Asset Management LLC | 2.61% |
| BlackRock Institutional Trust Company, N.A. | 2.08% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 13.42% |
| Investment Advisor | 9.24% |
| Investment Advisor/Hedge Fund | 5.64% |
| Individual Investor | 1.96% |
Related Instruments
+0.35%
-0.13%
+0.37%
-0.59%
-1.80%
-0.69%
+0.62%
-0.67%
+0.96%
+0.31%
-0.16%
+0.18%
-0.26%
+0.41%
-1.23%
-0.85%
+4.73%
-0.43%
+0.24%
+0.62%
FAQs
What is the current price of FibroGen Ord Shs (KYNB)?
The current price of FibroGen Ord Shs (KYNB) is 3.68.
What is the symbol of FibroGen Ord Shs?
The ticker symbol of FibroGen Ord Shs is KYNB.
What is the 52-week high of FibroGen Ord Shs?
The 52-week high of FibroGen Ord Shs is 10.47.
What is the 52-week low of FibroGen Ord Shs?
The 52-week low of FibroGen Ord Shs is 3.50.
What is the market capitalization of FibroGen Ord Shs?
The market capitalization of FibroGen Ord Shs is 14.90M.
Is FibroGen Ord Shs (KYNB) currently rated as Buy, Hold, or Sell?
According to analysts, FibroGen Ord Shs (KYNB) has an overall rating of Buy, with a price target of 38.50.
What is the Earnings Per Share (EPS TTM) of FibroGen Ord Shs (KYNB)?
The Earnings Per Share (EPS TTM) of FibroGen Ord Shs (KYNB) is 40.47.